IMPORTANT PRODUCT INFORMATION
The Systane® iLux2® is indicated for the application of localized heat and pressure therapy in adult patients with meibomian gland dysfunction (MGD), which is associated with evaporative dry eye, and to capture/store digital images and video of the meibomian glands.
Do NOT use the Systane® iLux2® in patients with the following conditions: Patients whose pupils have been pharmaceutically dilated; patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months); patients with active ocular herpes zoster or simplex of eye or eyelid or a history of these within prior 3 months; patients with cicatricial lid margin disease; patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months; patients with an ocular surface abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia; or patients with permanent makeup or tattoos on their eyelids.
Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.
The Disposable may not fit all eyes, such as eyes with small palpebral fornices. Use of the Systane® iLux2® is NOT recommended in patients with the following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease conditions that cause dry eye; in patients who are taking medications known to cause dryness; patients with punctal plugs, or patients who have undergone ocular surgery within prior 3 months.
Potential Adverse Reactions:
Potential adverse effects may occur because of the procedure. These effects include but are not limited to, the onset or increase in: eyelid/eye pain requiring discontinuation of the treatment procedure, eyelid irritation or inflammation, temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal abrasion, conjunctival edema or conjunctival injection (hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance, sensitivity to light).
Attention: Please refer to the User Manual for a complete list of contraindications, instructions for use, warnings and precautions for the Systane® iLux2®.
IMPORTANT PRODUCT INFORMATION
BlephEx® is intended for exfoliation and debridement of the eyelid margin, from the lash line back to the orifices of the meibomian glands.
Federal law restricts this device to sale by or on the order of a Physician or Optometrist. Only ophthalmologists, optometrists, and their trained staff are authorized to use the device. Failure to follow operating instructions could result in serious injury, including (but not limited to) injury of an eye. Avoid direct, prolonged contact with the eyeball and palpebral conjunctiva. Instill numbing drops into both of your patient’s eyes prior to use.
Attention: Please refer to the User Manual for a complete list of safety instructions and instructions for use for BlephEx®.
References: 1. Tauber J, Owen J, Bloomenstein M, Hovanesian J, Bullimore MA. Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial. Clin Ophthalmol. 2020;14:405-418. 2. Alcon data on file, 2019. 3. Alcon data on file, 2021. 4. MarketScope LLC. 2020 Dry Eye Products Report: A Global Market Analysis for 2019 to 2025. St. Louis, MO: MarketScope LLC; 2020. 5. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31:472-478. 6. TFOS. TFOS DEWS II. Available at http://www.tearfilm.org/dettreports-tfos dew_ii_report/32_30/eng/. Accessed May 9, 2018. 7. Alcon data on file, 2018. 8. Geffen D, Yeh TN, Merchea MM. iLUX® efficacy after one week of treatment. Poster presented at: American Academy of Optometry 2020 Annual Meeting—Academy 2020 At Home; October 7–22, 2020; Nashville, TN. 9. Siddireddy JS, Vijay AK, Tan J, Willcox M. Effect of Eyelid Treatments on Bacterial Load and Lipase Activity in Relation to Contact Lens Discomfort. Eye Contact Lens. 2020;46(4):245-253. 10. Connor CG, Choat C, Narayanan S, et al. Clinical Effectivenes of Lid Debridement with BlephEx Treatment. IOVS. 2015 June. 56:4440. 11. Choi MB, Stein R. Lid Hygiene Versus Lid Hygiene Plus Microblepharoexfoliation for the Treatment of Demodex folliculorum Blepharitis. Acta Scientific Ophthalmology. 2020:3(9): 29-35. 12. Alcon data on file, 2020.